Results 61 to 70 of about 724,864 (240)

Hepatitis B Virus Screening and Vaccination [PDF]

open access: yes, 2019
Hepatitis B is a virus that mostly affects the liver, it could be asymptomatic and if left untreated or undetected, could lead to liver cancer, cirrhosis or even death. When Hepatitis B virus enters the body, it could be detected as early as 30 days post
Umeh, Uwaezu J
core   +1 more source

Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis [PDF]

open access: yesWorld Journal of Hepatology, 6(10):759-765, 2014, 2014
AIM: To investigate the predictability of interleukin-28B single nucleotide polymorphism rs12979860 with respect to sustained virological response (SVR) in chronically hepatitis C virus (HCV) genotype-1 patients treated with a protease-inhibitor and pegylated interferon-$\alpha$ (Peg-INF-$\alpha$) based triple-therapy.
arxiv   +1 more source

Ranking of Administrative Districts of Almaty City by Incidence of Hepatitis B and C [PDF]

open access: yesInternational Journal of Biomedicine, 2017
The incidence of acute and chronic hepatitis B and C in the districts of Almaty city over the past 10 years is presented in this article.
Lyazat Zh. Orakbay   +3 more
doaj   +1 more source

Treatment of Chronic Hepatitis B [PDF]

open access: yes, 2005
Chronic hepatitis B is still a major health problem in Indonesia. Unfortunately, to date, treatment of chronic HBV (Hepatitis B virus) infection had not shown satisfactory Result.
Gani, R. A. (Rino)   +2 more
core   +1 more source

Using survival curves for comparison of ordinal qualitative data in clinical studies [PDF]

open access: yesarXiv, 2009
Background and Objective: The survival-agreement plot was proposed and improved to assess the reliability of a quantitative measure. We propose the use of survival analysis as an alternative non-parametric approach for comparison of ordinal qualitative data. Study Design and Setting: Two case studies were presented.
arxiv  

The natural history of chronic hepatitis B infection [PDF]

open access: yes, 1997
Chronic hepatitis B infection is a global health problem that affects about 300 million people. Of these, 75% are Chinese. Most Chinese who become chronic carriers, contract the virus during the perinatal period.
Lai, CL, Lau, GKK, Wu, PC
core  

A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection [PDF]

open access: yes, 2010
Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection.
AS Lok   +35 more
core   +3 more sources

METABOLIC AND CARDIOVASCULAR COMORBIDITIES IN BULGARIAN PATIENTS WITH CHRONIC VIRAL B AND C HEPATITIS [PDF]

open access: yesJournal of IMAB
Recent epidemiologic data on chronic viral B and C hepatitis in Bulgaria are limited.The evolution of these infections depends on liver complications and the presence of nonliver comorbidities.
Radoslava Tsrancheva   +10 more
doaj   +1 more source

Hepatitis C Virus Epidemic Control Using a Nonlinear Adaptive Strategy [PDF]

open access: yesarXiv, 2020
Hepatitis C is a viral infection that appears as a result of the Hepatitis C Virus (HCV), and it has been recognized as the main reason for liver diseases. HCV incidence is growing as an important issue in the epidemiology of infectious diseases. In the present study, a mathematical model is employed for simulating the dynamics of HCV outbreak in a ...
arxiv  

“To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana

open access: yesBMC Public Health, 2020
Background People with a condition subject to stigmatisation, such as chronic hepatitis B, face the dilemma of whether or not to disclose their status. In Ghana, 12.3% of the adult population has the hepatitis B virus (HBV). One key strategy for breaking
Charles Ampong Adjei   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy